2023
DOI: 10.3390/cancers15020341
|View full text |Cite
|
Sign up to set email alerts
|

Dysfunctional Lipid Metabolism—The Basis for How Genetic Abnormalities Express the Phenotype of Aggressive Prostate Cancer

Abstract: Prostate cancer is the second most frequent cancer in men, with increasing prevalence due to an ageing population. Advanced prostate cancer is diagnosed in up to 20% of patients, and, therefore, it is important to understand evolving mechanisms of progression. Significant morbidity and mortality can occur in advanced prostate cancer where treatment options are intrinsically related to lipid metabolism. Dysfunctional lipid metabolism has long been known to have a relationship to prostate cancer development; how… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…From pathway enrichment, PF-L metabolites potentially regulate the AMPK signaling pathway, EGFR tyrosine kinase inhibitor resistance, miRNAs in cancer, prostate cancer, steroid and lipid metabolism, SCF-KIT and PIK3/Akt signaling pathways, EPH-ephrin mediated cell repulsion, and the VEGFA-VEGFR2 pathway. Collectively, these pathways were discovered to significantly affect the tumorigenesis, growth, progression, energy regulation, metastasis, and adhesion of PCa cells [ 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 ].…”
Section: Discussionmentioning
confidence: 99%
“…From pathway enrichment, PF-L metabolites potentially regulate the AMPK signaling pathway, EGFR tyrosine kinase inhibitor resistance, miRNAs in cancer, prostate cancer, steroid and lipid metabolism, SCF-KIT and PIK3/Akt signaling pathways, EPH-ephrin mediated cell repulsion, and the VEGFA-VEGFR2 pathway. Collectively, these pathways were discovered to significantly affect the tumorigenesis, growth, progression, energy regulation, metastasis, and adhesion of PCa cells [ 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 ].…”
Section: Discussionmentioning
confidence: 99%
“…Reprogramming of fatty acid signaling and metabolic pathways accompanies the progression of PC [29,30]. FABP5 is the principal FABP that is upregulated in advanced PC and is implicated as a critical driver of PC metastasis [5][6][7][8].…”
Section: Discussionmentioning
confidence: 99%